Charles Schwab Investment Advisory, Inc. Novartis Ag Transaction History

Charles Schwab Investment Advisory, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$70.67 - $99.01 $311 Million - $436 Million	-4,398,928 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$84.35 - $95.37 $8.16 Million - $9.22 Million	96,711 Added 2.25%	4,398,928 $417 Million
Q3 2019 Nov 14, 2019	BUY	$85.54 - $94.26 $6.25 Million - $6.88 Million	73,039 Added 1.73%	4,302,217 $374 Million
Q2 2019 Aug 12, 2019	BUY	$75.4 - $92.8 $8.96 Million - $11 Million	118,863 Added 2.89%	4,229,178 $386 Million
Q1 2019 May 14, 2019	BUY	$75.32 - $86.15 $5.01 Million - $5.73 Million	66,495 Added 1.64%	4,110,315 $395 Million
Q4 2018 Feb 13, 2019	BUY	$73.66 - $82.02 $2.95 Million - $3.28 Million	40,017 Added 1.0%	4,043,820 $347 Million
Q3 2018 Nov 14, 2018	BUY	$66.94 - $77.43 $4.35 Million - $5.03 Million	64,993 Added 1.65%	4,003,803 $345 Million
Q2 2018 Aug 09, 2018	BUY	$64.91 - $73.36 $256 Million - $289 Million	3,938,810 New	3,938,810 $298 Million

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Advisory, Inc., based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Advisory, Inc. with notifications on news.